Delivery Order SPE2DB20D7061-SPE2DB24FSNS1

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,303.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 45 gram tubes of Adapalene 0.1% cream and has an ultimate completion date of January 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,001.70, is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 31, 2025. The contract is for the supply of Adapalene 0.1% Cream, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,460.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adapalene 0.1% Cream, a pharmaceutical product, with an ultimate completion date of December 11, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, valued at $2,147.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of 45 gram tubes of Adapalene 0.1% cream. The contract has a firm fixed price and an ultimate completion date of May 28, 2024. AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal healthcare programs, particularly within military and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 45 gram tubes of 0.1% Adapalene cream. The contract has a ceiling value of $2,059.58 and a completion date of August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the government to efficiently...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,870.15 firm fixed-price order is for the supply of Adapalene 0.1% cream, a topical acne medication. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Adapalene 0.1% cream, a topical retinoid medication, valued at $2,532.51. The contract has a period of performance through August 16, 2022 and utilizes a firm fixed-price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Adapalene 0.1% Cream, a topical medication, to support military and federal healthcare programs. The contract has a ceiling value of $6,571.64 and a period of performance through December 31, 2024. It is a Firm Fixed Price contract, meaning the price will not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Adapalene 0.1% cream, a topical acne medication, with a ceiling value of $1,143.50 and a performance period through February 2025. The contract is not designated as a set-aside and was awarded as an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,881.32 firm fixed-price contract is for the delivery of Adapalene 0.1% Cream, 45 gm, with a completion date of May 19, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB24FSNS1
    Delivery Order

This federal contract award, valued at $4,831.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adapalene 0.1% Cream, a topical medication, with a period of performance through June 20, 2024.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:16 AM